376 makale bulundu

Delayed Disease Onset Report in UK Biobank: Implications for Prodromal Studies in Parkinson's Disease.

Birleşik Krallık Biyobank'ta Gecikmiş Hastalık Onset Raporu: Parkinson Hastalığında Prodromal Çalışmalar için İmplikasyonlar.

Zolfaghari S, Kouchache T, Delva A, Bouhadoun S, Kuhlencord M, Pelletier A, Noyce AJ, Waters S, Belete D, Wilkinson T, Bush K, Morys F, Vo A, Rannikmae K, Dagher A, Postuma RB.

Mov Disord · 2025-12-04

DOI: 10.1002/mds.70147PMID: 41346098

Phase II pilot randomized trial of zonisamide for disease modification in prodromal Lewy body disease.

Hiraga K, Hattori M, Tamakoshi D, Satake Y, Fukushima T, Saito Y, Uematsu T, Tsuboi T, Sato M, Yokoi K, Suzuki K, Arahata Y, Ueki Y, Kinoshita F, Matsuda H, Murata A, Yamamoto M, Wakai M, Matsukawa N, Washimi Y, Katsuno M.

NPJ Parkinsons Dis · 2025-12-01

DOI: 10.1038/s41531-025-01198-3PMID: 41326428

Smartphone-based prediction of dopaminergic deficit in prodromal and manifest Parkinson's disease.

Prodromal ve manifesto Parkinson hastalığında dopaminerjik açığın akıllı telefon tabanlı tahmini.

Gunter KM, Groenewald K, Aubourg T, Lo C, Welch J, Razzaque J, van Hillegondsberg L, Nastasa A, Ratti PL, Orso B, Mattioli P, Pardini M, Raffa S, Massa F, McGowan DR, Bradley KM, Arnaldi D, Klein JC, Arora S, Hu MT.

NPJ Digit Med · 2025-12-01

DOI: 10.1038/s41746-025-02148-2PMID: 41326766

Association of Peripheral Blood Neutrophil-Lymphocyte Ratio With Motor and Cognitive Function in Prodromal Parkinson's Disease.

Prodromal Parkinson Hastalığında Motor ve Bilişsel Fonksiyonlu Periferal Kan Nötrofil-Lymphocyte Oranı Derneği.

Jun JS, Kang N, Byun K, Park K, Kim R.

Brain Behav · 2025-12-01

DOI: 10.1002/brb3.71141PMID: 41409015

Proteomic Exploration of L1CAM<sup>+</sup>-Extracellular Vesicles from Plasma of Manifest and Prodromal Parkinson's Disease.

L1CAM<sup>+</sup>-Manifest Plazma ve Prodromal Parkinson Hastalığından Hücre Dışı Veziküllerin Proteomik Keşfi.

Xylaki M, Chopra A, Kyriachenko Y, Scherer J, Otte B, Dakna M, Bartl M, Weber S, Schade S, Lenz C, Mollenhauer B.

Int J Mol Sci · 2025-11-28

DOI: 10.3390/ijms262311564PMID: 41373721

Depending on intensity, exercise improved or worsened pathology in a model of prodromal Parkinson's disease.

Yoğunluğa bağlı olarak, egzersiz, prodromal Parkinson hastalığının bir modelinde iyileştirilmiş veya kötüleşmiş patoloji.

Baldauf L, Feja M, Stanojlovic M, Strowig T, Visscher C, Schaeffer E, Berg D, Hankel J, Richter F.

NPJ Parkinsons Dis · 2025-11-23

DOI: 10.1038/s41531-025-01200-yPMID: 41274882

Using prodromal non-motor symptoms to predict Parkinson's disease onset and motor phenotype.

Parkinson hastalığının başlangıcını ve motor fenotipini tahmin etmek için prodromal motor olmayan semptomları kullanmak.

Pearson J, Badenoch JB, Van Wamelen D.

J Neurol Neurosurg Psychiatry · 2025-11-13

DOI: 10.1136/jnnp-2024-335429PMID: 40537250

Association of ultra-processed food consumption with prodromal, incident Parkinson's disease and mortality.

Chen X, Wang P, Luo W, Wang J, Sun L, Li Y, Zhang F, Gao X.

J Neurol Neurosurg Psychiatry · 2025-11-13

DOI: 10.1136/jnnp-2025-336045PMID: 40675802

Prodromal Parkinson's disease.

Grass L, Grimaldi S, Damier P.

Rev Neurol (Paris) · 2025-11-12

DOI: 10.1016/j.neurol.2025.06.012PMID: 41238316

Idiopathic hyposmia as a marker of prodromal Parkinson's disease - a cohort study.

Markovic-Obiago Z, Bestwick JP, Chohan H, Schrag A, Simonet C, Noyce AJ.

Sci Rep · 2025-11-11

DOI: 10.1038/s41598-025-23293-4PMID: 41219349

Correction: Integrated multi‑omics highlights alterations of gut microbiome functions in prodromal and idiopathic Parkinson's disease.

Villette R, Sunyer JO, Novikova PV, Aho VTE, Petrov VA, Hickl O, Busi SB, De Rudder C, Kunath BJ, Heintz-Buschart A, Trezzi JP, Halder R, Jäger C, Lebrun LA, Daujeumont A, Schade S, Janzen A, Jehmlich N, von Bergen M, Laczny CC, May P, Trenkwalder C, Oertel W, Mollenhauer B, Wilmes P.

Microbiome · 2025-11-07

DOI: 10.1186/s40168-025-02295-4PMID: 41204381

Deceleration Capacity as a Marker of Autonomic Cardiac Modulation in Prodromal and Manifest Parkinson's Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy.

Ruppert E, Mix N, Kesper K, Bauer A, Vadasz D, Ries V, Sittig E, Koehler U, Janzen A, Oertel WH.

Eur J Neurol · 2025-11-01

DOI: 10.1111/ene.70395PMID: 41165053